Part Details | USP CEFTAZIDIME INJECTION
6505-01-318-7405
Alternate Parts: 2G3535, NDC00173041200, NDC00173-0412-00, FORTAZ INJECTION PREMIXED, FORTAZ, 2G3535, NDC00173041200, NDC00173-0412-00, NDC00173041200, NDC00173-0412-00, FORTAZ, 6505-01-318-7405, 01-318-7405, 6505013187405, 013187405
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | APR 25, 1990 | 01-318-7405 | 51676 ( CEFTAZIDIME INJECTION, USP ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-318-7405
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| 2G3535 | 42275 | BAXTER HEALTHCARE CORPBAXTER SCIENTIFIC PRODUCTS DIV |
| NDC00173-0412-00 | 42275 | BAXTER HEALTHCARE CORPBAXTER SCIENTIFIC PRODUCTS DIV |
| FORTAZ INJECTION PREMIXED | 42275 | BAXTER HEALTHCARE CORPBAXTER SCIENTIFIC PRODUCTS DIV |
| FORTAZ | 42275 | BAXTER HEALTHCARE CORPBAXTER SCIENTIFIC PRODUCTS DIV |
| 2G3535 | 1G026 | BAXTER HEALTHCARE CORPORATION |
| NDC00173-0412-00 | 1G026 | BAXTER HEALTHCARE CORPORATION |
| NDC00173-0412-00 | 34006 | GLAXO WELLCOME INC |
| FORTAZ | 34006 | GLAXO WELLCOME INC |
Technical Data | NSN 6505-01-318-7405
| Characteristic | Specifications |
|---|---|
| PRIMARY CONTAINER TYPE | BAG WITH HANGING DEVICE, PLASTIC |
| PRIMARY CONTAINER CONTENT QUANTITY | 50.000 MILLILITERS |
| TOTAL PRIMARY CONTAINER QUANTITY | 24 |
| FEATURES PROVIDED | STERILE |
| SPECIAL FEATURES | PREMIXED IN ISO-OSMOTIC SOLUTION 2.2 GRAMS DEXTROSE HYDOUS (TO ADJUST OSMOLALITY); FROZEN; SINGLE DOSE BAGE WITH HANGING DEVICE; ONE PERMANENTLY ATTACHED OUTLET PORT SHALL ACCEPT AND RETAIN PIERCING DEVICE OF STOCK LISTED IV ADMINSTRATION SETS; SECOND OUTLET PORT IF PROVIDED,SHALL HAVE LATEX SLEEVE OR NATURAL RUBBER STOPPER AND SHALL BE SUITABLE FOR AN INJECTION |
| PROTECTIVE STORAGE FEATURE | FROZEN FOR PRESERVATION |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CEFTAZIDIME SODIUM IN DEXTROSE INJECTION 50ML BAG 24S |